Par Drugs and Chemicals Ltd (PAR) Stock Price & News

PAR:NSE

Par Drugs and Chemicals Ltd

₹118.00

+0.77%

(+0.90) 1D

Oct 12, 3:30:00 PM GMT+5:30 · INR

All symbols

	Symbol	Price	Change	% Change

Generating top insights for PAR...

Open

₹115.06

High

₹118.19

Low

₹112.10

Mkt. cap

1.45B

Avg. vol.

122.78K

Volume

12.62K

P/E ratio

10.01

52-wk high

₹180.00

52-wk low

₹78.05

EPS

₹11.78

No. of employees

118

Open

₹115.06

High

₹118.19

Low

₹112.10

Mkt. cap

1.45B

Avg. vol.

122.78K

Volume

12.62K

P/E ratio

10.01

52-wk high

₹180.00

52-wk low

₹78.05

EPS

₹11.78

No. of employees

118

Related stocks

MEDICAMEQ

Medicamen Biotech Ltd

₹303.90

+1.01%

AMANTA

Amanta Healthcare Ltd

₹181.00

-3.43%

SYNCOMF

Syncom Formulations (India) Ltd

₹23.18

-0.43%

SIGIND

Signet Industries Ltd

₹58.00

-5.00%

News stories

From web sources and news partners

TipRanks

4 minutes ago

Hyundai Motor Securities Prices S&P 500-Linked Bond, Raises KRW 8.24 Billion

BBN Times

2 hours ago

S&P 500 Slips 0.056% to 7,807.20, Holding Just Below Its Record as Chip Stocks Fall and Oil Climbs

BigGo Finance

2 hours ago

Wall Street Mixed: Dow Rises, Nasdaq Falls as Semiconductor Stocks Plunge

TradingView

1 hour ago

S&P 500, Nasdaq 100 End Lower On Chipmaker Weakness, While Salesforce Gains Aid Dow — META, MSFT, BMBL, CRM, SNAP In Focus

About Par Drugs and Chemicals Ltd

CEO-

Employees118

Founded1982

Headquarters-

SectorPharmaceutical industry

Websitepardrugs.com

All values in INR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	286.59M	293.40M	196.11M	312.80M
Cost of goods sold	107.24M	123.94M	100.57M	137.44M
Cost of revenue	107.24M	123.94M	100.57M	137.44M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	13.55M	14.10M	19.35M	16.89M
Operating expense	128.10M	118.14M	90.32M	121.20M
Total operating expenses	235.34M	242.08M	190.89M	258.64M
Operating income	51.25M	51.31M	5.22M	54.16M
Other non operating income	4.80M	13.26M	-37.70M	9.35M
EBT including unusual items	55.50M	64.42M	8.32M	63.30M
EBT excluding unusual items	55.50M	64.42M	-12.38M	63.30M
Income tax expense	14.21M	16.45M	-221.00K	16.17M
Effective tax rate	25.60%	25.53%	-2.66%	25.55%
Other operating expenses	105.14M	94.73M	61.69M	94.67M
Net income	41.30M	47.97M	8.54M	47.13M
Net profit margin	14.41%	16.35%	4.35%	15.07%
Earnings per share	-	-	-	-
Interest and investment income	-	-	20.10M	-
Interest expense	-549.00K	-148.00K	-	-214.00K
Net interest expenses	-549.00K	-148.00K	20.10M	-214.00K
Depreciation and amortization charges	9.41M	9.31M	9.28M	9.64M
EBITDA	60.47M	60.43M	14.48M	63.42M
Gain or loss from assets sale	-	-	-	-

Ask anything